Authors: Becker, C Piironen, T Pettersson, K Bjork, T Wojno, KJ Oesterling, JE Lilja, H

Citation: C. Becker et al., Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein 2 (hK2) in serum, J UROL, 163(1), 2000, pp. 311-316

Authors: Jacobsen, SJ Bergstralh, EJ Katusic, SK Guess, HA Darby, CH Silverstein, MD Oesterling, JE Lieber, MM

Citation: Sj. Jacobsen et al., Digital rectal examination and mortality from prostate cancer - Reply by the authors, UROLOGY, 53(4), 1999, pp. 864-864

Authors: Polascik, TJ Oesterling, JE Partin, AW

Citation: Tj. Polascik et al., Prostate specific antigen: A decade of discovery - What we have learned and where we are going, J UROL, 162(2), 1999, pp. 293-306

Authors: Thompson, IM Middleton, RG Optenberg, SA Austenfeld, MS Smalley, SR Cooner, WH Correa, RJ Miller, HC Oesterling, JE Resnick, MI Wasson, JH Roehrborn, CG

Citation: Im. Thompson et al., Have complication rates decreased after treatment for localized prostate cancer?, J UROL, 162(1), 1999, pp. 107-112

Authors: Vashi, AR Oesterling, JE

Citation: Ar. Vashi et Je. Oesterling, Radical retropubic prostatectomy for localized prostate cancer, TEXTBOOK OF PROSTATE CANCER, 1999, pp. 189-210